Grant: Master's Award: Canada Graduate Scholarships
Université de Montréal
$17,500.00
Elimination of CXC inflammatory chemokines by the chemokine receptor CXCR3
EF 2015-16
Résumé
Chemokine receptors are membrane proteins that detect chemokine gradients and induce migration of cells that express the receptors towards increasing concentrations of chemokines. This migration process called chemotaxis is essential to a variety of physiological processes during development and to assure normal function of the immune system. For instance, immune cells migrate by chemotaxis toward infection sites where inflammatory chemokines are locally secreted. Among the 22 chemokine receptors known until date, there are at least 4 that are classified as atypical chemokine receptors (ACKRs). These receptors control chemokine levels by mediating the internalisation and degradation of chemokines by the cells expressing ACKRs. ACKRs play an important role in immunity and inflammation because chemokine degradation limits inflammation and immune cell recruitment. This is particularly important in the context of inflammatory disorders, and could be important in the case of inflammation related to pregnancy complications such as pre-eclampsia and spontaneous pre-term birth.Our studies concern a specific chemokine receptor named CXCR3 that is expressed on T cells, and induces migration of T cells toward inflammation sites by detecting gradients of three inflammatory chemokines CXCL10 and CXCL11. This chemokine receptor exceptionally shows the ability to both act as a classical chemokine receptor and an atypical chemokine receptor, able to modulate levels of its ligands. We therefore aim to have a better understanding of the function of CXCR3 in the regulation of chemokine gradients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
350172
Name
Girard Mélanie
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Elimination of CXC inflammatory chemokines by the chemokine receptor CXCR3
Programtype2
Studentship Programs
Orgnameinp2
Université de Montréal
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autoimmune Diseases; Chemokine Receptors; Chemokines; Inflammatory Bowel Disease; Inflammatory Diseases; Migration
Abstract
Chemokine receptors are membrane proteins that detect chemokine gradients and induce migration of cells that express the receptors towards increasing concentrations of chemokines. This migration process called chemotaxis is essential to a variety of physiological processes during development and to assure normal function of the immune system. For instance, immune cells migrate by chemotaxis toward infection sites where inflammatory chemokines are locally secreted. Among the 22 chemokine receptors known until date, there are at least 4 that are classified as atypical chemokine receptors (ACKRs). These receptors control chemokine levels by mediating the internalisation and degradation of chemokines by the cells expressing ACKRs. ACKRs play an important role in immunity and inflammation because chemokine degradation limits inflammation and immune cell recruitment. This is particularly important in the context of inflammatory disorders, and could be important in the case of inflammation related to pregnancy complications such as pre-eclampsia and spontaneous pre-term birth.Our studies concern a specific chemokine receptor named CXCR3 that is expressed on T cells, and induces migration of T cells toward inflammation sites by detecting gradients of three inflammatory chemokines CXCL10 and CXCL11. This chemokine receptor exceptionally shows the ability to both act as a classical chemokine receptor and an atypical chemokine receptor, able to modulate levels of its ligands. We therefore aim to have a better understanding of the function of CXCR3 in the regulation of chemokine gradients.
Competitiondate
201512
Approvedterm2
1 yr 0 mth
Pinamesdelim
Girard, Mélanie
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~